KCNH1 and neoplasm: By NIRF imaging we showed a selective binding of the NIR fluorescently labelled mAb62 to Kv10.1-expressing MDA-MB-435S tumours in vivo, with a peak at 2 days post injection, which could be blocked by an excess of unlabelled mAb62.